Race Oncology Limited

ASX:RAC.AX

1.575 (AUD) • At close November 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q32015 Q22015 Q1
Omzet 04.0031.8121.32200.70800.38700.15900.22900.1700000000
Kosten van de omzet 0.7690.1410.1410.1410.1410.1410.1410.1410.1410.1410.1410.3730.0480.54500000000
Brutowinst -0.7693.8631.6721.181-0.1410.567-0.1410.247-0.1410.019-0.141-0.144-0.048-0.37500000000
Brutowinstmarge 00.9650.9220.89400.80100.63700.1180-0.6310-2.20200000000
Onderzoek- en ontwikkelingskosten 4.8726.1054.4283.1673.5462.2861.6640.5360.7360.5410.5090.6560.6270.6570.7140.497000000
Algemene en administratieve kosten 0.4610.4530.9490.5760.3020.3130.3430.3270.2750.2120.2010.2170.2560.2620.2610.1930.2380.130.07400.0050.002
Verkoop- en marketingkosten 0.1260.3060.2110.1120.0890.0870.1010.0730.0670.0370.0620.1820.7140.4970.2470.3040.05400000
Verkoop-, algemene en administratieve kosten 2.3223.3682.8492.2622.5252.8482.3021.6941.50.9020.9331.0071.982.2151.1191.4610.2930.130.07400.0050.002
Overige kosten 0000000000000000000000
Bedrijfskosten 7.1959.4737.2775.4296.075.1343.9662.2292.2361.4431.4431.8942.7823.1232.12.0970.1280.2060.08100.0060.003
Bedrijfsresultaat -7.964-9.613-7.418-5.569-6.211-5.275-4.106-2.37-2.377-1.583-1.583-2.035-2.827-3.495-2.087-2.097-0.262-0.168-0.0840-0.006-0.003
Bedrijfsresultaat ratio 0-2.401-4.093-4.2130-7.4520-6.1170-9.9350-8.9070-20.52700000000
Totaal overige inkomsten en kosten netto -0.192-0.0530.094-0.164-0.169-0.255-0.174-0.0780.033-0.078-0.0490.0080.0090.007-0.0030.0160.145-0.0320.003000
Inkomen voor belasting -8.156-9.667-7.324-5.734-6.38-5.53-4.28-2.447-2.344-1.661-1.632-2.027-2.818-3.488-2.09-2.081-0.118-0.2-0.0810-0.006-0.003
Inkomen voor belasting ratio 0-2.415-4.041-4.3370-7.8120-6.3180-10.4250-8.8710-20.48900000000
Belastingkosten 0-4.003-1.812-1.3220-0.7080-0.3870-0.1590000000.145-0.0320.003000
Nettowinst -8.156-5.663-5.512-4.412-6.38-4.822-4.28-2.06-2.344-1.502-1.632-2.027-2.818-3.488-2.09-2.081-0.118-0.2-0.0810-0.006-0.003
Nettowinstmarge 0-1.415-3.041-3.3370-6.8120-5.3180-9.4250-8.8710-20.48900000000
WPA (Winst Per Aandeel) -0.049-0.035-0.034-0.027-0.04-0.033-0.032-0.016-0.021-0.015-0.02-0.026-0.04-0.055-0.04-0.04-0.01-0.018-0.0030-00
Verwaterde WPA -0.049-0.035-0.034-0.027-0.04-0.033-0.032-0.016-0.021-0.015-0.02-0.026-0.04-0.055-0.04-0.04-0.01-0.018-0.0030-00
EBITDA -8.272-9.473-7.277-5.429-6.07-5.134-3.966-2.229-2.236-1.443-1.443-1.895-2.701-3.37-1.92-2.0140.145-0.0320.003000
EBITDA ratio 0-2.366-4.015-4.1060-7.2540-5.7550-9.0530-8.2920-19.79300000000